Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Capital funding was the preserve of central government, which considered that so far as the laboratory at BPL was concerned "expenditure on up-grading should be reviewed and minimised pending a decision on the laboratory's future."

  • Read more about Capital funding was the preserve of central government, which considered that so far as the laboratory at BPL was concerned "expenditure on up-grading should be reviewed and minimised pending a decision on the laboratory's future."

Dr Maycock stated: "DHSS, in order to be able to carry with confidence its responsibility for providing the transfusion service in England and Wales, should consider fostering the development of a central transfusion research laboratory."

  • Read more about Dr Maycock stated: "DHSS, in order to be able to carry with confidence its responsibility for providing the transfusion service in England and Wales, should consider fostering the development of a central transfusion research laboratory."

Professor Garrott Allen wrote to Dr William Maycock stating: "As you know" Cutter's Konyne was "extraordinarily hazardous".

  • Read more about Professor Garrott Allen wrote to Dr William Maycock stating: "As you know" Cutter's Konyne was "extraordinarily hazardous".

It was apparent that there was some resistance by some clinicians to the use of heat-treated product.

  • Read more about It was apparent that there was some resistance by some clinicians to the use of heat-treated product.

Dr James Smith proposed to Dr Lane some first outline proposals for programmes to research tackling the transmission of viruses by coagulation factor concentrates. This proposal, according to Dr Lane, marked "the start of a move towards a viral inactivation programme."

  • Read more about Dr James Smith proposed to Dr Lane some first outline proposals for programmes to research tackling the transmission of viruses by coagulation factor concentrates. This proposal, according to Dr Lane, marked "the start of a move towards a viral inactivation programme."

Dr Lane's account of 1981 was one of his battles to secure a commitment from the government to redevelop BPL, and to fund the improvements necessary following an adverse Medicines' Inspectorate report.

  • Read more about Dr Lane's account of 1981 was one of his battles to secure a commitment from the government to redevelop BPL, and to fund the improvements necessary following an adverse Medicines' Inspectorate report.

Dr Lane complained that the "Department of Health policy was that Regional Health Authorities were to all intents and purposes responsible for allocation of budgets, and the Department of Health would not intervene in the exercise of their discretion."

  • Read more about Dr Lane complained that the "Department of Health policy was that Regional Health Authorities were to all intents and purposes responsible for allocation of budgets, and the Department of Health would not intervene in the exercise of their discretion."

According to Dr Lane, a "requirement for central funding for research and development was a continuous theme in 1981."

  • Read more about According to Dr Lane, a "requirement for central funding for research and development was a continuous theme in 1981."

BPL planned to apply dry heat treatment to all the Factor 8 produced at BPL because it was shown that heat treatment appeared to inactivate the HTLV-3 virus which by then had been identified as the cause of AIDS.

  • Read more about BPL planned to apply dry heat treatment to all the Factor 8 produced at BPL because it was shown that heat treatment appeared to inactivate the HTLV-3 virus which by then had been identified as the cause of AIDS.

Dr Richard Lane recorded that no work was done by BPL during 1981 to research heat treatment.

  • Read more about Dr Richard Lane recorded that no work was done by BPL during 1981 to research heat treatment.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 223
  • Page 224
  • Page 225
  • Page 226
  • Current page 227
  • Page 228
  • Page 229
  • Page 230
  • Page 231
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.